Infermedica

• 26/01/2022
• Pre-Series B
• $30,000,000

Infermedica's mission is to make healthcare accessible, convenient, and affordable for everyone, by automating primary care from symptom to outcome.

The company's Medical Guidance Platform is a set of intelligent healthcare technologies that enables early symptom assessment and digital triage, and supports communication between physicians and patients.

At the core of Infermedica’s technologies are its Medical Knowledge Base, Inference Engine and API gateway.

Infermedica’s platform can be used by healthcare providers, insurers, and telemedicine companies to minimize inappropriate use of medical services, and improve patient navigation and user satisfaction.

Symptom checking features provided by Infermedica can be freely implemented on webpages, mobile apps, and patient portals. It is possible through flexible API, or our ready-to-use solutions: Triage and Intake.

Infermedica technologies can also help to detect emergencies and support healthcare professionals by giving them early access to health information and recommendations.

Patient safety is the main focus of physicians, engineers, and scientists working, side-by-side, at Infermedica. The algorithms use dynamic interview scenarios to predict the lists of possible conditions. They analyze the common language and verify combinations of symptoms.

Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards.

Infermedica has been adeptly interweaving medical and technical expertise into their technologies since 2012, to support industry leaders such as Global Excel, Gothaer, Médis, Microsoft, and Sana Kliniken.

Infermedica is now being used in more than 30 countries, in 20 languages, and has completed more than 10 million successful health checks to date.

To learn more about the company and its products, visit infermedica.com.

Also check out Symptomate, our consumer-facing symptom checker. Available for free use on both mobile and web at symptomate.com

---

---